A Facebook post from Dr. Linden Karas on the nonstop advertising people see across Instagram and magazines. Only the opening line is available.
Recap by typeshit. Post by Facebook on Facebook.
A sponsored-style explainer that walks through semaglutide versus tirzepatide and the post-shortage compounding limits, while featuring telehealth company Mochi Health.
Good Morning America looks at GLP-1 use spreading from adults to a growing number of teens being treated for obesity.
ABC News' chief medical correspondent walks through the latest Novo Nordisk GLP-1 medication and what sets it apart from drugs already on the market.
18:51
A doctor walks through four of the most talked about weight loss drugs in one overview, covering the big names people ask about most.
She says kids who meet certain criteria can get GLP-1 agonists, usually through a paediatric endocrinologist, since it's a specialised medication.
GoodRx flags medullary thyroid cancer and MEN2 syndrome, in yourself or your family, as reasons some GLP-1 weight loss medications shouldn't be used.
Loading…